Low Transferrin Saturation (TSAT) Indicating Iron Deficiency
Low transferrin saturation (for example, TSAT 15%) indicates inadequate circulating iron available for erythropoiesis and is consistent with iron deficiency in appropriate clinical contexts.[1][2] Serum ferritin is the single most useful marker of iron deficiency, while TSAT can be helpful when ferritin may be falsely normal (for example, inflammation or chronic disease). [1]
Interpretation of a TSAT of 15%
- TSAT reflects the fraction of transferrin binding sites occupied by iron.[3]
- TSAT <20% in combination with supportive ferritin criteria supports a diagnosis of iron deficiency.[2]
- Serum ferritin is the most specific test for iron deficiency in the absence of inflammation.[1]
Evaluation for Iron Deficiency Etiology
Laboratory confirmation of iron deficiency
- Confirm iron deficiency with iron studies before gastrointestinal investigation.[1]
- Initial confirmed iron deficiency work-up should include evaluation for anemia and associated conditions through complete blood count and iron indices.[1]
- When inflammation is possible, interpretation of ferritin may be affected, and additional iron studies and inflammatory markers can be used to support diagnosis.[2][4]
Clinical history and baseline assessment
- Obtain a detailed history to identify likely sources of iron loss or reduced intake or absorption.[1]
- In adults with confirmed iron deficiency anemia, initial investigations should include urinalysis or urine microscopy, screening for celiac disease, and endoscopic examination of the upper and lower gastrointestinal tract in appropriate cases.[1]
Diagnostic strategy using treatment response
- In anemic patients, a good response to iron therapy supports absolute iron deficiency. [1]
- A hemoglobin rise of ≥10 g/L within a 2-week timeframe is highly suggestive of absolute iron deficiency, even when iron studies are equivocal.[1]
Treatment of Iron Deficiency
Initiation of iron replacement therapy
- Treatment for iron deficiency anemia is generally initiated after laboratory confirmation, so that treatment and diagnostic investigation proceed in parallel.[1]
- A beneficial hemoglobin rise is typically seen within 2 weeks after starting oral iron replacement therapy.[1]
Oral iron therapy selection and administration
- Traditional oral iron salts (ferrous sulfate, ferrous gluconate, and ferrous fumarate) are standard therapies for iron deficiency anemia.[1]
- Lower doses and less frequent administration can be effective and may reduce adverse effects.[1]
- Oral iron should be taken in a fasting state when possible because taking iron with meals can reduce bioavailability substantially.[1]
- Coadministration of vitamin C with oral iron is not recommended because it does not improve hematological response or iron loading.[1]
Intravenous iron therapy indications
- Intravenous iron may be preferable when ongoing significant bleeding is present, when malabsorption due to gastrointestinal disease is present, when iron deficiency coexists with anemia of inflammation, or when administration or adherence is problematic.[1]
- Intravenous iron should be considered when there is intolerance or pharmacodynamic failure to oral iron or continued bleeding.[1]
- Intravenous iron has demonstrated superiority to continuing oral therapy in cases with inadequate hemoglobin rise after 2 weeks of oral therapy (defined as <10 g/L rise) or ongoing menorrhagia.[1]
Monitoring and non-response evaluation
- Early monitoring should detect patients who are not responding to or who are intolerant of oral iron.[1]
- Failure to respond to oral iron can reflect nonadherence, malabsorption, systemic disease, bone marrow pathology, hemolysis, continued bleeding, or concurrent vitamin B12 or folic acid deficiency.[1]
Targets for Hemoglobin Recovery
- Adequate response is typically supported by an early hemoglobin increase after iron initiation, and further monitoring is used to ensure ongoing recovery.[1]
- In the BSG framework, a hemoglobin rise of ≥10 g/L within 2 weeks supports absolute iron deficiency.[1]
- Monitoring regimens in practice aim to accept an adequate hematologic response when hemoglobin rises into the normal range or by approximately 20 g/L, depending on the monitoring point and clinical context.[1]
Common Pitfalls to Avoid
- Proceeding directly to gastrointestinal investigation without confirming iron deficiency with iron studies can reduce diagnostic accuracy.[1]
- Relying on ferritin alone when inflammation may be present can misclassify iron status, because TSAT and inflammatory context may need consideration.[1][2]
- Delaying recognition of inadequate response to oral iron can prolong unresolved iron deficiency; lack of hemoglobin rise by 2 weeks should prompt evaluation for non-response causes and consideration of alternative therapy.[1]
Ongoing Management of the Underlying Cause
- Iron replacement therapy treats iron deficiency but does not address the underlying etiology of iron loss or impaired absorption.[1]
- In adults with confirmed iron deficiency anemia without an obvious explanation, gastrointestinal investigation on an urgent basis should be considered to evaluate for serious pathology.[1]